Malignant Bone Neoplasm — Trials

Malignant Bone Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

152 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 38
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 31.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07193550	A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)	recruiting	Phase 2	70	M.D. Anderson Cancer CenterOTHER	1	Sep 25, 2026	clinicaltrials
NCT03965234	Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases	recruiting	Phase 1 / Phase 2	99	Roswell Park Cancer InstituteOTHER	1	Aug 21, 2026	clinicaltrials